| Source HCPCS Code |
|
Target NDC Code |
J9070
|
⇄
|
00013-5616-93
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
|
⇄
|
00013-5626-93
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
|
⇄
|
00013-5636-70
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
|
⇄
|
00013-5646-70
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
|
⇄
|
00015-0502-41
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
|
⇄
|
00015-0505-41
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
|
⇄
|
00015-0506-41
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
00781-3233-94
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
00781-3244-94
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
00781-3255-94
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0935-01
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
05/31/2023 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0935-25
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
05/31/2023 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
|
⇄
|
10019-0936-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
|
⇄
|
10019-0937-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0938-01
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0938-25
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0939-01
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0939-50
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0942-01
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0942-10
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0943-01
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0943-25
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0944-01
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0944-50
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0945-01
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0945-10
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
12/16/2016 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0955-01
CYCLOPHOSPHAMIDE 500 MG VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0955-50
CYCLOPHOSPHAMIDE 500 MG VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0956-01
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0956-16
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0957-01
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
10019-0957-11
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
16714-0857-01
CYCLOPHOSPHAMIDE 1 GM
|
| Detail Information |
| Relationship Start Date |
03/04/2019 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
16714-0858-01
CYCLOPHOSPHAMIDE 2 GM
|
| Detail Information |
| Relationship Start Date |
03/04/2019 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
16714-0859-01
CYCLOPHOSPHAMIDE 500 MG
|
| Detail Information |
| Relationship Start Date |
03/04/2019 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
38779-0506-03
CYCLOPHOSPHAMIDE (U.S.P.)
|
| Detail Information |
| Relationship Start Date |
1/1/2011 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
NA |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
38779-0506-04
CYCLOPHOSPHAMIDE (U.S.P.)
|
| Detail Information |
| Relationship Start Date |
1/1/2011 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
NA |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
38779-0506-05
CYCLOPHOSPHAMIDE (U.S.P.)
|
| Detail Information |
| Relationship Start Date |
1/1/2011 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
NA |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
50742-0519-02
CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
07/30/2020 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
50742-0520-05
CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
07/30/2020 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
50742-0521-10
CYCLOPHOSPHAMIDE (MDV) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
12/06/2021 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
51407-0748-02
CYCLOPHOSPHAMIDE 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
03/20/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
51407-0749-05
CYCLOPHOSPHAMIDE 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
03/20/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
51407-0750-10
CYCLOPHOSPHAMIDE 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
03/20/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
55150-0270-01
CYCLOPHOSPHAMIDE (SDV,PF,LATEX-FREE) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/31/2021 |
| Relationship End Date |
03/31/2022 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
55150-0271-01
CYCLOPHOSPHAMIDE (SDV,PF,LATEX-FREE) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/31/2021 |
| Relationship End Date |
03/31/2022 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0370-27
CYCLOPHOSPHAMIDE (SDV,USP,PF) 500 MG
|
| Detail Information |
| Relationship Start Date |
11/05/2018 |
| Relationship End Date |
07/07/2020 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0371-32
CYCLOPHOSPHAMIDE (SDV,USP,PF) 1 GM
|
| Detail Information |
| Relationship Start Date |
11/05/2018 |
| Relationship End Date |
07/07/2020 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0372-32
CYCLOPHOSPHAMIDE (SDV,USP,PF) 2 GM
|
| Detail Information |
| Relationship Start Date |
11/05/2018 |
| Relationship End Date |
07/07/2020 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0442-26
CYCLOPHOSPHAMIDE (SDV;USP) 500 MG
|
| Detail Information |
| Relationship Start Date |
11/30/2020 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0443-27
CYCLOPHOSPHAMIDE (SDV;USP) 1 GM
|
| Detail Information |
| Relationship Start Date |
11/30/2020 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0444-32
CYCLOPHOSPHAMIDE (SDV;USP) 2 GM
|
| Detail Information |
| Relationship Start Date |
11/30/2020 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0564-22
CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
11/21/2022 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
68001-0565-28
CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
11/21/2022 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
70121-1238-01
CYCLOPHOSPHAMIDE (SDV,USP,PF) 500 MG
|
| Detail Information |
| Relationship Start Date |
06/12/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
70121-1239-01
CYCLOPHOSPHAMIDE (SDV,USP,PF) 1 GM
|
| Detail Information |
| Relationship Start Date |
06/12/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
70121-1240-01
CYCLOPHOSPHAMIDE (SDV,USP,PF) 2 GM
|
| Detail Information |
| Relationship Start Date |
06/12/2018 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
70860-0218-03
CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2021 |
| Relationship End Date |
08/10/2023 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
70860-0218-05
CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2021 |
| Relationship End Date |
08/10/2023 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
70860-0218-10
CYCLOPHOSPHAMIDE 2 GM/10 ML
|
| Detail Information |
| Relationship Start Date |
02/25/2021 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
72572-0083-01
CYCLOPHOSPHAMIDE 2 GM VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
72572-0085-01
CYCLOPHOSPHAMIDE 1 GM VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
Cyclophosphamide, 100 mg
|
⇄
|
72572-0087-01
CYCLOPHOSPHAMIDE 500 MG VIA
|
| Detail Information |
| Relationship Start Date |
01/01/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
72603-0104-01
CYCLOPHOSPHAMIDE (SDV,USP,PF) 500 MG
|
| Detail Information |
| Relationship Start Date |
05/07/2020 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
72603-0326-01
CYCLOPHOSPHAMIDE (SDV,USP,PF) 1 GM
|
| Detail Information |
| Relationship Start Date |
05/07/2020 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
81298-8110-01
CYCLOPHOSPHAMIDE (SDV) 500 MG
|
| Detail Information |
| Relationship Start Date |
12/08/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
81298-8112-01
CYCLOPHOSPHAMIDE (SDV) 1 GM
|
| Detail Information |
| Relationship Start Date |
12/08/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9070
CYCLOPHOSPHAMIDE, 100 MG
|
⇄
|
81298-8114-01
CYCLOPHOSPHAMIDE (SDV) 2 GM
|
| Detail Information |
| Relationship Start Date |
12/08/2023 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|